Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| IDEAYA Biosciences, Inc.(IDYA) | 3,500,000 | 3,345,000 | -155,000 | $57.33M | $70.31M | 9.39% | +$12.98M |
| Akero Therapeutics Inc | 1,200,000 | 1,200,000 | 0 | $48.58M | $64.03M | 8.55% | +$15.46M |
| Revolution Medicines, Inc.(RVMD) | 1,600,000 | 1,700,000 | +100,000 | $56.58M | $62.54M | 8.35% | +$5.97M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 0 | 450,000 | +450,000 | $0 | $47.75M | 6.38% | +$47.75M |
| Disc Medicine, Inc.(IRON) | 394,342 | 700,000 | +305,658 | $19.58M | $37.07M | 4.95% | +$17.50M |
| Avidity Biosciences Inc | 350,000 | 950,000 | +600,000 | $10.33M | $26.98M | 3.60% | +$16.65M |
| Keros Therapeutics, Inc.(KROS) | 2,000,000 | 2,000,000 | 0 | $20.38M | $26.70M | 3.57% | +$6.32M |
| Biogen Inc.(BIIB) | 0 | 200,000 | +200,000 | $0 | $25.12M | 3.36% | +$25.12M |
| United Therapeutics Corporation(UTHR) | 0 | 85,000 | +85,000 | $0 | $24.42M | 3.26% | +$24.42M |
| Arvinas, Inc.(ARVN) | 0 | 3,300,000 | +3,300,000 | $0 | $24.29M | 3.24% | +$24.29M |
| Janux Therapeutics, Inc.(JANX) | 1,650,000 | 1,000,000 | -650,000 | $44.55M | $23.10M | 3.09% | -$21.45M |
| Ocular Therapeutix, Inc.(OCUL) | 2,300,000 | 2,200,000 | -100,000 | $16.86M | $20.42M | 2.73% | +$3.56M |
| Erasca, Inc.(ERAS) | 13,000,000 | 15,000,000 | +2,000,000 | $17.81M | $19.05M | 2.54% | +$1.24M |
| Neurocrine Biosciences, Inc.(NBIX) | 0 | 150,000 | +150,000 | $0 | $18.85M | 2.52% | +$18.85M |
| Dyne Therapeutics, Inc.(DYN) | 500,000 | 1,900,000 | +1,400,000 | $5.23M | $18.09M | 2.42% | +$12.86M |
| Immunocore Holdings plcADS(IMCR) | 0 | 575,000 | +575,000 | $0 | $18.04M | 2.41% | +$18.04M |
| Structure Therapeutics IncADS | 425,000 | 850,000 | +425,000 | $7.36M | $17.63M | 2.35% | +$10.27M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 0 | 50,000 | +50,000 | $0 | $15.13M | 2.02% | +$15.13M |
| Design Therapeutics, Inc.(DSGN) | 4,217,627 | 4,217,627 | 0 | $16.28M | $14.21M | 1.90% | -$2.07M |
| Krystal Biotech, Inc.(KRYS) | 0 | 100,000 | +100,000 | $0 | $13.75M | 1.84% | +$13.75M |
| Olema Pharmaceuticals, Inc.(OLMA) | 3,208,875 | 3,208,875 | 0 | $12.07M | $13.67M | 1.83% | +$1.60M |
| Celldex Therapeutics, Inc.(CLDX) | 0 | 600,000 | +600,000 | $0 | $12.21M | 1.63% | +$12.21M |
| Biohaven Ltd.(BHVN) | 0 | 700,000 | +700,000 | $0 | $9.88M | 1.32% | +$9.88M |
| Xencor, Inc.(XNCR) | 0 | 1,250,000 | +1,250,000 | $0 | $9.82M | 1.31% | +$9.82M |
| Praxis Precision Medicines, Inc.(PRAX) | 0 | 225,000 | +225,000 | $0 | $9.46M | 1.26% | +$9.46M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 350,000 | 200,000 | -150,000 | $13.67M | $9.44M | 1.26% | -$4.23M |
| Cidara Therapeutics Inc | 0 | 190,000 | +190,000 | $0 | $9.25M | 1.24% | +$9.25M |
| Crescent Biopharma, Inc.(CBIO) | 0 | 553,686 | +553,686 | $0 | $8.94M | 1.19% | +$8.94M |
| Legend Biotech CorporationADS(LEGN) | 0 | 250,000 | +250,000 | $0 | $8.87M | 1.19% | +$8.87M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 0 | 130,000 | +130,000 | $0 | $8.21M | 1.10% | +$8.21M |
| Maze Therapeutics, Inc.(MAZE) | 936,914 | 611,914 | -325,000 | $10.32M | $7.51M | 1.00% | -$2.81M |
| Enliven Therapeutics Inc | 240,000 | 350,000 | +110,000 | $4.72M | $7.02M | 0.94% | +$2.30M |
| Jade Biosciences Inc | 0 | 625,000 | +625,000 | $0 | $6.24M | 0.83% | +$6.24M |
| Annexon, Inc.(ANNX) | 4,000,000 | 2,410,000 | -1,590,000 | $7.72M | $5.78M | 0.77% | -$1.94M |
| Metsera Inc | 0 | 200,000 | +200,000 | $0 | $5.69M | 0.76% | +$5.69M |
| Trevi Therapeutics, Inc.(TRVI) | 424,715 | 850,000 | +425,285 | $2.67M | $4.65M | 0.62% | +$1.98M |
| Immunovant, Inc.(IMVT) | 275,000 | 275,000 | 0 | $4.70M | $4.40M | 0.59% | -$299.8K |
| Verastem, Inc.(VSTM) | 0 | 1,000,000 | +1,000,000 | $0 | $4.15M | 0.55% | +$4.15M |
| Astria Therapeutics Inc | 500,000 | 700,000 | +200,000 | $2.67M | $3.75M | 0.50% | +$1.08M |
| Bicara Therapeutics Inc | 0 | 400,000 | +400,000 | $0 | $3.72M | 0.50% | +$3.72M |
| Aclaris Therapeutics, Inc.(ACRS) | 2,222,222 | 1,850,000 | -372,222 | $3.40M | $2.63M | 0.35% | -$773.0K |
| Rapport Therapeutics, Inc.(RAPP) | 208,910 | 208,910 | 0 | $2.10M | $2.38M | 0.32% | +$279.9K |
| Unicycive Therapeutics, Inc.(UNCY) | 0 | 473,562 | +473,562 | $0 | $2.26M | 0.30% | +$2.26M |
| Septerna, Inc.(SEPN) | 134,202 | 109,202 | -25,000 | $777.0K | $1.15M | 0.15% | +$377.2K |
| Nuvation Bio Inc.W EXP 02 10 202(NUVB) | 66,666 | 66,666 | 0 | $15.9K | $18.0K | 0.00% | +$2.1K |
| 89bio Inc | 2,500,000 | 0 | -2,500,000 | $18.18M | $0 | — | -$18.18M |
| Aerovate Therapeutics Inc | 1,400,000 | 0 | -1,400,000 | $3.51M | $0 | — | -$3.51M |
| Allakos Inc | 2,900,000 | 0 | -2,900,000 | $660.0K | $0 | — | -$660.0K |
| Artiva Biotherapeutics, Inc.(ARTV) | 145,089 | 0 | -145,089 | $435.3K | $0 | — | -$435.3K |
| BioNTech SEADS(BNTX) | 200,000 | 0 | -200,000 | $18.21M | $0 | — | -$18.21M |
| COMPASS Pathways plcADS(CMPS) | 2,000,000 | 0 | -2,000,000 | $5.72M | $0 | — | -$5.72M |
| Crinetics Pharmaceuticals In | 350,000 | 0 | -350,000 | $11.74M | $0 | — | -$11.74M |
| Geron Corporation(GERN) | 8,000,000 | 0 | -8,000,000 | $12.72M | $0 | — | -$12.72M |
| Glycomimetics Inc | 5,400,000 | 0 | -5,400,000 | $1.13M | $0 | — | -$1.13M |
| Nuvalent Inc | 500,000 | 0 | -500,000 | $35.46M | $0 | — | -$35.46M |
| Soleno Therapeutics Inc | 250,000 | 0 | -250,000 | $17.86M | $0 | — | -$17.86M |
| Solid Biosciences Inc | 100,000 | 0 | -100,000 | $370.0K | $0 | — | -$370.0K |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 1,700,000 | 0 | -1,700,000 | $26.13M | $0 | — | -$26.13M |
| Unicycive Therapeutics Inc | 5,078,927 | 0 | -5,078,927 | $2.92M | $0 | — | -$2.92M |
| Xenon Pharmaceuticals Inc.(XENE) | 650,000 | 0 | -650,000 | $21.81M | $0 | — | -$21.81M |